The emergence of drug-resistance in Enterococcus faecalis V583 through acquisition of resistance genes has been correlated to the absence of CRISPR-loci. Here, the presence of a bona-fide CRISPR locus in E. faecalis V583 (Accid:NC 004668.1) at 2238156 with a single 20 nt repeat is demonstrated. The presence of a putative endonuclease Cas1 13538 nucleotides away from the repeat substantiates this claim. This Cas1 (628 aa) is highly homologous (Eval:5e-34) to a Cas1 from Pseudanabaena biceps (Accid:WP 009625648.1, 697 aa), which belongs to the enigmatic family of RT-CRISPR locus. Such significant similarity to a Cas protein, the presence of a topoisomerase, other DUF (domain of unknown function) proteins as is often seen in CRISPR loci, and other hypothetical proteins indicates that this is a bona-fide CRISPR locus. Further corroboration is provided by expression of both the repeat and the Cas1 gene in existing RNA-seq data (SRX3438611). Since so little is known of even well-studied species like E. faecalis V583 having many hypothetical proteins, computational absence of evidence should not be taken as evidence of absence (both crisprfinder and PILER-CR do not report this as a CRISPR locus). It is unlikely that bacteria would completely give up defense against its primeval enemies (viruses) to bolster its fight against the newly introduced antibiotics. 
Introduction
Antibiotic-resistant bacterial infections are linked to increased morbidity and mortality in hospitals [1] . Enterococcus faecalis is a gram-positive, commensal bacteria found in the gastrointestinal tract of humans. One strain, E. faecalis V583, has developed resistance to vancomycin [2] and chloramphenicol treatment causing great concern [3] . Mobile DNA, easily transferred among different strains and species, has been shown to be a large contributing factor to this resistance [4, 5] .
Clustered regularly interspaced short palindromic repeats (CRISPR) is a prokaryotic adaptive defense system in bacteria [6] . Through this mechanism bacteria assimilate (memorize) short sequences of invading genomes (spacers) within repeats [7] [8] [9] , and uses proximal effector proteins (Cas) [10] [11] [12] to cleave subsequent infections from the same organism [13, 14] . Although CRISPR-Cas loci have been identified in some E faecalis strains (for e.g. T1 and X98) [15] [16] [17] , it was not found in E. faecalis V583 [16] . Subsequent work has correlated the emergence of drug-resistance in E. faecalis V583 to the absence of CRISPR-loci [16, 18, 19] .
Here, a CRISRP-Cas locus is reported in E. faecalis V583, with expression found for both the repeat and the Cas1 gene in existing RNA-seq data.
Results and discussion

Repeat and proximal Cas1 gene
The 20 nt repeat at 2238156 (GGGCAGTCGGCGTTGACCGC) is shown in Fig 1. The presence of an putative endonuclease Cas1 (628 aa) 13538 nucleotides away from the repeat substantiates this claim (Table 1). This Cas1 is highly homologous (Eval:5e-34) to the N-terminal of a Cas1 from Pseudanabaena biceps (Accid:WP 009625648.1, 697 aa), which is annotated as a group II intron reverse transcriptase (RT). The Cterminal of this protein has been established to have nucleolytic activity using a homolog from Archaeoglobus Fulgidus (PDBid:4N06), indicating this belongs to the enigmatic RT-CRISPR family [20] [21] [22] .
RNA-seq evidence:
Expression was found for both the repeat (SRR6339668.9502786.1, SRR6339668.8954887.2, SRR6339668.4564129.1, SRR6339668.4376029.2, SRR6339668.1205782.2) and the Cas1 gene (Fig 2) based on the SRA:SRX3438611.
Conclusions:
Computational absence of evidence should not be taken as evidence of absence. Neither crisprfinder [23] , nor PILER-CR [24] report this as a CRISPR locus. Repeats with relevant proximal proteins should give enough credence to look for CRISPR-loci [25] . Claims that 'major bacterial lineages are essentially devoid of CRISPR-Cas viral defense systems' should also be revisited [26] , since its unlikely they have failed to "learn" in billions of years the CRISPR defense mechanism against viruses from their peers -something that they did in decades against human introduced antibiotics. For example, the claim that the entireChlamydiae phylum lack CRISPR-Cas systems [26] was shown to be mistaken [27] . Also, it is unlikely that bacteria would give up defense against its primeval enemies (viruses) to bolster its fight against the newly introduced antibiotics.
Materials and methods
ftp://ftp.ncbi.nih.gov/genomes/refseq/bacteria/ provided bacterial genomes and annotation. The getorf program from the EMBOSS suite [13] was used to obtain the ORFs (SI ORFS.fa). ORFs that are 15000 nt from the loci are annotated on both sides using YeATS [28-30] based on the Ncbi annotation. MSA figures were generated using the ENDscript server [31] . RNAfold [32] was used to predict the secondary structure of the RNA repeat. MAFFT (v7.123b) [33] was used for doing the multiple sequence alignment (MSA). Table 1 .
